| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13,749 |
13,728 |
$1.68M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,035 |
13,836 |
$1.17M |
| 31231 |
|
5,049 |
4,972 |
$781K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,724 |
10,017 |
$719K |
| 31575 |
|
3,517 |
3,484 |
$350K |
| 31237 |
|
601 |
526 |
$126K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
1,099 |
1,045 |
$121K |
| 92557 |
|
4,196 |
4,184 |
$114K |
| 95024 |
|
542 |
541 |
$110K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
594 |
570 |
$99K |
| 99205 |
Prolong outpt/office vis |
652 |
651 |
$95K |
| 99215 |
Prolong outpt/office vis |
882 |
849 |
$93K |
| 70486 |
|
1,013 |
876 |
$78K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,138 |
2,058 |
$73K |
| 31579 |
|
554 |
545 |
$72K |
| 92550 |
|
4,192 |
4,183 |
$70K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,112 |
2,256 |
$66K |
| 92612 |
|
371 |
368 |
$50K |
| 92587 |
|
2,824 |
2,817 |
$43K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
680 |
656 |
$42K |
| 92524 |
|
548 |
528 |
$38K |
| 95117 |
|
4,232 |
1,463 |
$36K |
| 99442 |
|
631 |
530 |
$35K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,253 |
1,788 |
$31K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,387 |
1,919 |
$30K |
| 92540 |
|
411 |
408 |
$28K |
| 69210 |
|
778 |
708 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,087 |
915 |
$25K |
| 97162 |
|
405 |
401 |
$24K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
407 |
297 |
$23K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
557 |
486 |
$22K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,272 |
1,128 |
$18K |
| 70480 |
|
208 |
206 |
$17K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
976 |
748 |
$17K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
713 |
567 |
$15K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,047 |
843 |
$15K |
| 95992 |
|
540 |
514 |
$14K |
| 30520 |
|
26 |
26 |
$14K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
879 |
652 |
$13K |
| 92610 |
|
263 |
262 |
$13K |
| 92537 |
|
411 |
408 |
$12K |
| 95800 |
|
190 |
189 |
$11K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
554 |
472 |
$11K |
| 92526 |
|
186 |
145 |
$8K |
| 30140 |
|
40 |
40 |
$8K |
| 97035 |
|
347 |
244 |
$3K |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
598 |
515 |
$2K |
| 99441 |
|
64 |
57 |
$2K |
| 92520 |
|
12 |
12 |
$998.89 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
66 |
62 |
$903.98 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
14 |
13 |
$534.86 |
| 99422 |
|
19 |
18 |
$390.18 |
| 92567 |
|
12 |
12 |
$182.31 |
| 92591 |
|
190 |
188 |
$75.00 |